Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitisArends, S., Wink, F., Veneberg, J., Bos, R., van Roon, E., van der Veer, E., Maas, F. & Spoorenberg, A., 5-Jul-2020, In : British Journal of Clinical Pharmacology. 8 p.
Research output: Contribution to journal › Article › Academic › peer-review
Aims: To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements has an effect on lumbar spine and hip bone mineral density (BMD) in ankylosing spondylitis (AS) patients starting tumour necrosis factor-alpha inhibitors or receiving conventional treatment. Secondly, to explore the development of radiographic vertebral fractures.
Methods: Patients from the Groningen Leeuwarden AS cohort receiving bisphosphonates based on clinical indication and available 2-year follow-up BMD measurements were included. BMD of lumbar spine (L1-L4) and hip (total proximal femur) were measured using dual-energy X-ray absorptiometry. Spinal radiographs (Th4- L4) were scored for vertebral fractures according to the Genant method.
Results: In the 20 included patients (median 52 years, 14 males), lumbar spine and hip BMD Z-scores increased significantly; median from -1.5 (interquartile range [QR] -2.2 to 0.4) to 0.1 (IQR -1.5 to 1.0); P <.001 and median from -1.0 (IQR -1.6 to -0.7) to -0.8 (IQR -1.2 to 0.0); P = .006 over 2 years, respectively. In patients also treated with tumour necrosis factor-alpha inhibitors (n = 11), lumbar spine and hip BMD increased significantly (median 2-year change +8.6% [IQR 2.4 to 19.6; P = .009] and +3.6% [IQR 0.7-9.0; P = .007]). In patients on conventional treatment (n = 9), lumbar spine BMD increased significantly (median 2-year change +3.6%; IQR 0.7 to 9.0; P = .011) and no improvement was seen in hip BMD (median -0.6%; IQR -3.1 to 5.1; P = .61). Overall, younger AS males with limited spinal radiographic damage showed most improvement in lumbar spine BMD. Four mild radiographic vertebral fractures developed in 3 patients and 1 fracture increased from mild to moderate over 2 years in postmenopausal women and middle-aged men.
Conclusion: This explorative observational cohort study in AS showed that 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements significantly improves lumbar spine BMD. Mild radiographic vertebral fractures still occurred.
|Number of pages||8|
|Journal||British Journal of Clinical Pharmacology|
|Early online date||12-Jun-2020|
|Publication status||Published - 5-Jul-2020|
- ankylosing spondylitis, bisphosphonates, bone mineral density, tumour necrosis factor-alpha inhibitors, vertebral fractures, VERTEBRAL FRACTURES, PAMIDRONATE, ALENDRONATE, PREVALENCE, INFLIXIMAB, INCREASES, THERAPY, RISK, MG